missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-18/IL-1F4 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
289.00 CHF - 1730.00 CHF
Spezifikation
Zugriffsnummer | Q14116 |
---|---|
Zur Verwendung mit (Anwendung) | Bioactivity |
Gen-ID (Entrez) | 3606 |
Molekulargewicht | Observed M.W.: 19kDa, reducing conditions, Theoretical M.W.: 18kDa |
Quelle | E. coli-derived human IL-18/IL-1F4 protein Tyr37-Asp193 |
Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
---|---|---|---|---|---|---|---|---|---|
Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
18711588
|
R&D Systems™
9124-IL-010/CF |
10 μg |
289.00 CHF
10 Mikrogramm |
Verfügbar ab: 18-12-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
18374767
|
R&D Systems™
9124-IL-050/CF |
50 μg |
494.00 CHF
50 Mikrogramm |
Verfügbar ab: 18-12-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
18745939
|
R&D Systems™
9124-IL-500/CF |
500 μg |
1730.00 CHF
500 Mikrogramm |
Verfügbar ab: 18-12-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
Beschreibung
The Recombinant Human IL-18/IL-1F4 Protein is derived from E. coli. The Recombinant Human IL-18/IL-1F4 Protein has been validated for the following applications: Bioactivity.Spezifikation
Q14116 | |
3606 | |
E. coli-derived human IL-18/IL-1F4 protein Tyr37-Asp193 | |
<0.10 EU per 1μg of the protein by the LAL method. | |
IL-18/IL-1F4 | |
Measured by its ability to induce IFN-gamma secretion by KG-1 human acute myelogenous leukemia cells in the presence of TNF-alpha . The ED50 for this effect is typically 1.5-9ng/mL. | |
Human | |
E. coli-derived Tyr37-Asp193 |
Bioactivity | |
Observed M.W.: 19kDa, reducing conditions, Theoretical M.W.: 18kDa | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Iboctadekin, IFN-gamma-inducing factor, IGIF, IGIFIL-1 gamma, IL18, IL-18MGC12320, IL-1F4, IL1F4iboctadekin, IL-1g, Interferon gamma-inducing factor, interleukin 18 (interferon-gamma-inducing factor), Interleukin-1 gamma, interleukin-18 | |
IL18 | |
Unconjugated | |
Recombinant | |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining |
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts